Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 238

    1.

    Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.

    Clifford RM, Davis WA, Batty KT, Davis TM; Fremantle Diabetes Study.

    Diabetes Care. 2005 Apr;28(4):771-6.PMID: 15793171 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.

    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M; H6E-MC-GLAT study group.

    Clin Ther. 2005 May;27(5):554-67.PMID: 15978304 [PubMed - indexed for MEDLINE]Related articles

    3.

    A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA).

    Gagliardino JJ, Etchegoyen G; PENDID-LA Research Group.

    Diabetes Care. 2001 Jun;24(6):1001-7.PMID: 11375360 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.

    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.

    Clin Ther. 2005 Sep;27(9):1383-91.PMID: 16291411 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

    Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

    Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.

    Comaschi M, Coscelli C, Cucinotta D, Malini P, Manzato E, Nicolucci A; SFIDA Study Group--Italian Association of Diabetologists (AMD).

    Nutr Metab Cardiovasc Dis. 2005 Jun;15(3):204-11.PMID: 15955469 [PubMed - indexed for MEDLINE]Related articles

    11.

    A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain.

    Fornos JA, Andrés NF, Andrés JC, Guerra MM, Egea B.

    Pharm World Sci. 2006 Apr;28(2):65-72. Epub 2006 Jun 22.PMID: 16791717 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improvement of glycaemic control in type 2 diabetes: favourable changes in blood pressure, total cholesterol and triglycerides, but not in HDL cholesterol, fibrinogen, Von Willebrand factor and (pro)insulin.

    Becker A, van der Does FE, van Hinsbergh VW, Heine RJ, Bouter LM, Stehouwer CD.

    Neth J Med. 2003 Apr;61(4):129-36.PMID: 12852722 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention.

    Odegard PS, Goo A, Hummel J, Williams KL, Gray SL.

    Ann Pharmacother. 2005 Mar;39(3):433-40. Epub 2005 Feb 8.PMID: 15701763 [PubMed - indexed for MEDLINE]Related articles

    15.

    Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.

    Bebb C, Kendrick D, Stewart J, Coupland C, Madeley R, Brown K, Burden R, Sturrock N.

    Diabet Med. 2005 Oct;22(10):1364-71.PMID: 16176198 [PubMed - indexed for MEDLINE]Related articles

    16.

    A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes.

    Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, Dittus RS, Weinberger M, Pignone MP.

    Am J Med. 2005 Mar;118(3):276-84.PMID: 15745726 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of structured hospital-based care compared with standard care for Type 2 diabetes-The Asker and Baerum Cardiovascular Diabetes Study, a randomized trial.

    Johansen OE, Gullestad L, Blaasaas KG, Orvik E, Birkeland KI.

    Diabet Med. 2007 Sep;24(9):1019-27. Epub 2007 May 17.PMID: 17509068 [PubMed - indexed for MEDLINE]Related articles

    19.

    Generalizability and persistence of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes.

    Johnson JA, Eurich DT, Toth EL, Lewanczuk RZ, Lee TK, Majumdar SR.

    Diabetes Care. 2005 Apr;28(4):783-8.PMID: 15793173 [PubMed - indexed for MEDLINE]Related articlesFree article